Dirk Staessen

1.2k total citations
14 papers, 588 citations indexed

About

Dirk Staessen is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Dirk Staessen has authored 14 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Genetics and 3 papers in Epidemiology. Recurrent topics in Dirk Staessen's work include Inflammatory Bowel Disease (5 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Gastrointestinal motility and disorders (3 papers). Dirk Staessen is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Gastrointestinal motility and disorders (3 papers). Dirk Staessen collaborates with scholars based in Belgium, Australia and Netherlands. Dirk Staessen's co-authors include W. Van Steenbergen, Johan Fevery, J. De Groote, Valeer Desmet, Raf Sciot, Denis Franchimont, Filip Baert, Séverine Vermeire, Martine De Vos and M. Verlinden and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Dirk Staessen

10 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Staessen Belgium 8 249 217 203 200 103 14 588
L. Humbert France 9 97 0.4× 141 0.6× 203 1.0× 65 0.3× 54 0.5× 15 562
George Yanni United States 10 122 0.5× 214 1.0× 126 0.6× 44 0.2× 129 1.3× 26 457
Ian Johnston United Kingdom 10 174 0.7× 298 1.4× 192 0.9× 57 0.3× 50 0.5× 17 540
David Silvers United States 8 143 0.6× 144 0.7× 111 0.5× 86 0.4× 9 0.1× 13 374
K. Beckh Germany 12 92 0.4× 254 1.2× 53 0.3× 40 0.2× 66 0.6× 36 518
AR Zinsmeister United States 7 152 0.6× 141 0.6× 148 0.7× 139 0.7× 123 1.2× 13 425
B D Linaker United Kingdom 8 118 0.5× 94 0.4× 67 0.3× 76 0.4× 47 0.5× 13 355
Sigurbjörn Birgisson Iceland 7 170 0.7× 209 1.0× 194 1.0× 121 0.6× 10 0.1× 13 449
Angiola Fontanella Italy 9 317 1.3× 85 0.4× 69 0.3× 48 0.2× 168 1.6× 21 424
Bani Chander Roland United States 16 74 0.3× 454 2.1× 505 2.5× 26 0.1× 33 0.3× 29 907

Countries citing papers authored by Dirk Staessen

Since Specialization
Citations

This map shows the geographic impact of Dirk Staessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Staessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Staessen more than expected).

Fields of papers citing papers by Dirk Staessen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Staessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Staessen. The network helps show where Dirk Staessen may publish in the future.

Co-authorship network of co-authors of Dirk Staessen

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Staessen. A scholar is included among the top collaborators of Dirk Staessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Staessen. Dirk Staessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Carbone, Florencia, Alain Vandenberghe, Lieselot Holvoet, et al.. (2022). A double‐blind randomized, multicenter, placebo‐controlled study of itopride in functional dyspepsia postprandial distress syndrome. Neurogastroenterology & Motility. 34(8). e14337–e14337. 15 indexed citations
2.
Vyver, Gysèle Van de, et al.. (2021). Gastric MALT-Lymphoma: more than Helicobacter Pylori. Acta Gastro Enterologica Belgica. 84(4). 653–655. 2 indexed citations
3.
Houte, Karen Van den, Florencia Carbone, Jolien Schol, et al.. (2020). Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care. Clinical Gastroenterology and Hepatology. 19(8). 1620–1626. 25 indexed citations
4.
Vandamme, Timon, et al.. (2020). Gastrointestinal: Refractory dyspepsia due to primary gastric amyloidosis: Sometimes you have to dig deeper. Journal of Gastroenterology and Hepatology. 36(5). 1149–1149.
5.
Liefferinckx, Claire, Bram Verstockt, Ann Gils, et al.. (2019). Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn’s Disease Who Failed Biologic Therapies: A National Cohort Study. Journal of Crohn s and Colitis. 13(11). 1401–1409. 82 indexed citations
6.
Liefferinckx, Claire, Bram Verstockt, Ann Gils, et al.. (2019). Mo1910 – Long-Term Clinical Efficacy of Ustekinumab in Refractory Crohn’s Disease: A Multi-Centre Belgian Cohort Study. Gastroenterology. 156(6). S–882.
7.
Liefferinckx, Claire, Bram Verstockt, Ann Gils, et al.. (2019). DOP33 Long-term clinical efficacy of ustekinumab in refractory Crohn’s disease : a multi-centre Belgian cohort study. Journal of Crohn s and Colitis. 13(Supplement_1). S044–S045.
8.
Vos, Martine De, Olivier Dewit, Geert D’Haens, et al.. (2011). Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis. Journal of Crohn s and Colitis. 6(5). 557–562. 115 indexed citations
9.
Vos, Martine De, Olivier Dewit, Geert D’Haens, et al.. (2011). Calprotectin as a Biomarker for Remission in UC Patients Under IFX Therapy. Gastroenterology. 140(5). S–276.
10.
Talley, Nicholas J., M. Verlinden, William J. Snape, et al.. (2000). Failure of a motilin receptor agonist (ABT‐229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double‐blind placebo‐controlled trial. Alimentary Pharmacology & Therapeutics. 14(12). 1653–1661. 182 indexed citations
11.
Steenbergen, W. Van, et al.. (1998). Nimesulide-induced acute hepatitis: evidence from six cases. Journal of Hepatology. 29(1). 135–141. 59 indexed citations
12.
Nevens, Frederik, Dirk Staessen, Raf Sciot, et al.. (1994). Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. Gastroenterology. 106(2). 459–463. 35 indexed citations
13.
Nevens, Frederik, Dirk Staessen, Raf Sciot, et al.. (1991). Incomplete septal cirrhosis (ICS),a syndrome intermediate between cirrhosis and obliterative portal venopathy. Journal of Hepatology. 13. S56–S56. 1 indexed citations
14.
Sciot, Raf, Dirk Staessen, Boudewijn Van Damme, et al.. (1988). Incomplete septal cirrhosis: histopathological aspects. Histopathology. 13(6). 593–603. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026